Cells lacking DNA topoisomerase II beta are resistant to genistein

Miguel López-Lazaro1, Elaine Willmore, Caroline A Austin

  • 1Institute for Cell and Molecular Biosciences, The Medical School, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, NE2 4HH, United Kingdom.

Insights

Dietary flavonoids genistein and luteolin impact DNA topoisomerases (topos). Genistein inhibits topoisomerase II (topo II), while luteolin inhibits topoisomerase I (topo I), suggesting roles in anticancer and carcinogenic effects.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Flavonoids possess potential anticancer and carcinogenic properties.
  • DNA topoisomerases (topos) are implicated in these effects.
  • Genistein and luteolin are dietary flavonoids of interest.

Purpose of the Study:

  • To evaluate genistein and luteolin as DNA topoisomerase I (topo I) and topoisomerase II (topo II) poisons and catalytic inhibitors.
  • To investigate the role of topo II beta in genistein's cellular effects.

Main Methods:

  • Utilized the TARDIS cell-based assay in K562 leukemia cells.
  • Assessed topo I and topo II DNA complex formation.
  • Employed XTT and clonogenic assays to measure cell growth inhibition and cytotoxicity.
  • Examined genistein's effects in murine cells lacking topo II beta.

Main Results:

  • Genistein and luteolin induced topo II-DNA complexes, but not significant topo I-DNA complexes.
  • Genistein catalytically inhibited topo II, while luteolin inhibited topo I.
  • Cells lacking topo II beta were resistant to genistein's growth inhibition and cytotoxicity.
  • Genistein exposure led to high levels of topo II beta-DNA complexes.

Conclusions:

  • Topoisomerase II beta plays a crucial role in genistein-induced cell growth inhibition and death.
  • The study elucidates mechanisms by which genistein and luteolin interact with topoisomerases.
  • Findings contribute to understanding the dual role of flavonoids in cancer and carcinogenicity.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...